Australia. Private Health Insurance Ombudsman
28 Jun 2013 - Removal of the rebate from Lifetime Health Cover (LHC) - from 1 July, the Rebate will not apply to LHC loading.... Read more
Australia. Private Health Insurance Administration Council
3 July 2013 - Capital Adequacy Standard – Interest Rate June 2013 - Private Health Insurance Administration Council (PHIAC) has determined that the interest rate applicable for the calculation of the renewal option amount to be applied by all private health insurers for the quarter ended 30 June 2013 is 2.471% per annum.
25 June 2013 - 2012–13 End of Year Reporting Requirements. 2012–13 End of Year Reporting Requirements
Australian Health Practitioner Regulation Agency (AHPRA)
9 July 2013 - AHPRA has published a request for quotation (RFQ) for developing a customised Governance training course. Submissions close 19 August 2013.| Read article
2 July 2013 - The Chinese Medicine Board of Australia releases its latest communique.| Read Article
4 July 2013 - The Medical Radiation Practice Board of Australia (MRPBA) has issued a position statement on using a protected title, such as "radiographer", under the National Law.| Read Article
5 July 2013 - The Ministerial Council has extended a transitional provision under section 284 of the National Law to 30 June 2015 for midwives in private practice providing intrapartum care for women who choose to homebirth.| Read Article
5 July 2013 - The Nursing and Midwifery Board of Australia releases its latest newsletter.| Read Article
3 July 2013 - The National Board has published important information on new applications for notation as an eligible midwife.| Read Article
1 July 2013 - The Occupational Therapy Board of Australia invites occupational therapists in South Australia to a free breakfast forum.| Read Article
5 July 2013 - The Osteopathy Board releases its latest communique.| Read Article
2 July 2013 - The Physiotherapy Board of Australia releases its latest communique. | Read Article
Australian Commission on Safety & Quality in Health Care
Australian Institute of Health & Welfare
Australia. National Health and Medical Research Council (NHMRC)
Australia. Therapeutic Goods Administration
11 July 2013 - Australian Public Assessment Reports for prescription medicines (AusPARs). Added imatinib (as mesylate) (glivec), exenatide (byetta) and docetaxel (docetaxel-PF).
11 July 2013 - Documents released under Section 11C of the Freedom of Information Act 1982. Added Freedom of Information (FOI) 242-1213 and FOI 244-1213.
10 July 2013 - Orphan drugs. Added elosulfase-alpha.
10 July 2013 - Consultation: Options for reform of the regulatory framework for pharmacy compounding-This consultation closing date has been extended to 5pm, Friday 26 July 2013.
9 July 2013 - Advisory Committee on the Safety of Medicines (ACSOM). Added two new members.
9 July 2013 - GE Healthcare nuclear medicine imaging systems. GE Healthcare, in consultation with the Therapeutic Goods Administration (TGA), has initiated a recall for product correction for a number of its nuclear medicine imaging systems.
9 July 2013 - Cementless Columbus Knee System - used in knee replacements. Health professionals and consumers are advised that B. Braun Australia is withdrawing the cementless version of the Columbus Knee System from the Australian Register of Therapeutic Goods.
9 July 2013 - Hydroxyethyl starch (Voluven and Volulyte) and increased risk of mortality. The TGA has commenced a full risk benefit review of products containing hydroxyethyl starch.
9 July 2013 - Low value turnover application forms. Updated forms for 2013-14 financial year.
8 July 2013 - Complementary medicines: Cancellations from the ARTG following compliance review. Added four products cancelled from the Australian Register of Therapeutic Goods (ARTG) following compliance review for June 2013.
8 July 2013 - TGA Office of Complementary Medicines (OCM) road shows. A schedule informing stakeholders about the TGA's upcoming OCM roadshows in July and August.
8 July 2013 - Nite Rider capsules. The TGA has tested Nite Rider capsules and found that they contain an undeclared prescription substance.
8 July 2013 - Tocotrienols complex - palm: Proposed revision of draft compositional guideline, 2nd round consultation-Added submission received and TGA response.
8 July 2013 - Compositional guideline: Tocotrienols complex - palm. Added to current compositional guideline page.
5 July 2013 - A career as a Medical Officer at the TGA. The TGA employs about 35 medical officers, at various levels, in both full and part time positions. Additionally, we consistently seek applications from medical practitioners interested in working as medical officers at the TGA with non-ongoing opportunities.
5 July 2013 - Consultations on adoption of European Union guidelines in Australia. Added 8 guidelines proposed for adoption by TGA.
5 July 2013 - Early Warning System: health professional questions and answers. Questions and answers for health professionals about the Early Warning System.
5 July 2013 - Global crackdown against counterfeit and illegal medicines. Between 18 and 25 June 2013, the Australian Customs and Border Protection Service, the Therapeutic Goods Administration and the Australian Pesticides and Veterinary Medicines Authority took part in a week-long international crackdown on fake and illegal medicines purchased over the Internet.
5 July 2013 - Consultation: Regulation Impact Statement: Regulating the advertising of therapeutic goods to the general public. The closing date for this consultation has been extended to 19 July 2013.
4 July 2013 - Prescribing medicines in pregnancy database. Added fidaxomicin, pertuzumab, vismodegib, micafungin, retigabine, ruxolitinib phosphate.
Australia. National Mental Health Commission
11 July 2013 - Join the conversation.
1 July 2013 - Mentally healthy workplaces.
You might also be interested in...
© DLA Piper
This publication is intended as a general overview and discussion of the subjects dealt with. It is not intended to be, and should not used as, a substitute for taking legal advice in any specific situation. DLA Piper Australia will accept no responsibility for any actions taken or not taken on the basis of this publication.
DLA Piper Australia is part of DLA Piper, a global law firm, operating through various separate and distinct legal entities. For further information, please refer to www.dlapiper.com